STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more

The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.

Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout

STAT examines America's failure to address excessive alcohol use across decades.